| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.31 | 7e-14 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.33 | 2e-13 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-11 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.28 | 3e-11 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.29 | 3e-11 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.27 | 5e-11 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.35 | 1e-10 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.34 | 1e-09 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-09 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-08 |